A selective COX-2 inhibitor, meloxicam, as a treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxen

Clin Exp Rheumatol. 2002 Nov-Dec;20(6):874.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abdominal Pain / chemically induced*
  • Adolescent
  • Adult
  • Arthritis, Juvenile / drug therapy*
  • Arthritis, Juvenile / physiopathology
  • Child
  • Child, Preschool
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Joints / pathology
  • Joints / physiopathology
  • Male
  • Meloxicam
  • Naproxen / adverse effects*
  • Retrospective Studies
  • Severity of Illness Index
  • Thiazines / therapeutic use*
  • Thiazoles / therapeutic use*
  • Treatment Outcome

Substances

  • Cyclooxygenase Inhibitors
  • Thiazines
  • Thiazoles
  • Naproxen
  • Meloxicam